FeesSafety
Pluang+

Xometry posts 40% revenue growth, positive net income, and raises FY26 guidance on AI-driven manufacturing platform.

Market News
06 Nov 2026, 20:55 WIB
Seeking Alpha
View Source
Bullish
Xometry posts 40% revenue growth, positive net income, and raises FY26 guidance on AI-driven manufacturing platform.

Xometry reported strong Q3 results with 40% revenue growth, record margins, and positive GAAP net income, reaching a $1 billion+ revenue run rate. The company’s AI-powered manufacturing marketplace benefits from Siemens integration, AI innovation, and global expansion, supporting long-term growth. Management raised FY26 guidance and aims for over 20% incremental EBITDA margins. Despite AI risks for simple parts, Xometry’s proprietary data and focus on complex manufacturing maintain its competitive advantage and large market opportunity.

Xometry's recent strong Q3 performance provides context for readers interested in industrials. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 07, 2026 02:11 WIB: Among 135 priced US Industrials stocks tradable on Pluang, 82 rose and 52 fell today. Notable movers include RKLB at USD 52.24 with a 13.59% increase and a typical hold time of 34 days, ENVX at USD 2.71 up 12.71% with a typical hold time of 11 days, and ACHR at USD 4.32 rising 11.50% with a typical hold time of 21 days and 100% buy order activity.

More News

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...

Company Fundamentals
Neutral
3 hours ago
Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...

Company Fundamentals
Neutral
3 hours ago
Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...

Market News
Bullish
3 hours ago
Sodexo reports October 2026 share capital and voting rights update.

Sodexo reports October 2026 share capital and voting rights update.

Sodexo disclosed its monthly update on share capital and voting rights as of October 31, 2026. The company has 147,454,887 shares with actual voting rights totaling 216,485,145, reflecting shares with single and double voting rights. This update is p...

Company Fundamentals
Neutral
3 hours ago
Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo announced its monthly update on the total number of shares and voting rights as of October 31, 2026. The company has 147,454,887 shares composing its capital, with 216,485,145 exercisable voting rights and 218,335,896 theoretical voting rights...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App